Cisplatin-induced cytotoxicity in BSO-exposed renal proximal tubular epithelial cells: Sex, age, and species

Renal Failure

Volumn 27, Issue 5, 2005, Pages 629-633

  Lu, Yongke ^a   Kawashima, Akira ^b   Horii, Ikuo ^c   Zhong, Laifu ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

^b CHUGAI PHARMACEUTICAL CO LTD   (Japan)

^c PFIZER INC   (United States)

Author keywords

Age; BSO; Cisplatin; Renal tubular epithelial cells; Sex; Species

Indexed keywords

BUTHIONINE SULFOXIMINE; CISPLATIN; TETRAZOLIUM;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL GROWTH; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG INDUCED DISEASE; EPITHELIUM CELL; FEMALE; KIDNEY INJURY; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE EPITHELIUM; MALE; MONKEY; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BUTHIONINE SULFOXIMINE; CELL DEATH; CELL SURVIVAL; CELLS, CULTURED; CISPLATIN; DISEASE MODELS, ANIMAL; EPITHELIAL CELLS; FEMALE; HAPLORHINI; KIDNEY TUBULES, PROXIMAL; MALE; RATS; RATS, SPRAGUE-DAWLEY; SEX FACTORS; SPECIES SPECIFICITY;

EID: 24044435538     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.1080/08860220500200668     Document Type: Article

References (25)

1. Rosenberg, B. Fundamental studies with CP. Cancer 1985, 55, 2303-2316.
2. Pinzani, V.; Bressolle, F.; Haug, I.J.; Galtier, M.; Blayac, J.P. CP induced renal toxicity and toxicity-modulating strategies: a review. Cancer Chemother. Pharmacol. 1994, 35, 1-9.
3. Appenroth, D.; Braunlich, H. Age differences in cisplatinum nephrotoxicity. Toxicology 1984, 32 (4), 343-353.
4. Dobya, D.C.; Levi, J.; Jacobs, C.; Kosck, J.; Weiner, M.W. Mechanism of cisplatin nephrotoxicity: II. Morphologic observations. J. Pharmacol. Exp. Ther. 1980, 213, 551-556.
5. Sugihara, K.; Nakaro, S.; Koda, M.; Tanaka, K.; Fukuishi, N.; Gemba, M. Stimulatory effect of CP on production of lipid peroxidation in renal tissue. Jpn. J. Pharmacol. 1987, 43, 246-252.
6. Hannemann, J.; Baumann, K. CP-induced lipid peroxidation and decrease of gluconeogenesis in rat kidney cortex: different effect of antioxidant and radical scavengers. Toxicology 1988, 51, 119-132.
7. Zhong, L.F.; Zhang, J.G.; Zhang, M.; Ma, S.L.; Xia, Y.X. Protection against CP-induced lipid peroxidation and kidney damage by procaine in rat. Arch. Toxicol. 1990, 64, 599-600.
8. Zhang, J.G.; Zhong, L.F.; Zhang, M.; Xia, Y.X. Protection effects of procaine on oxidative stress and toxicities of renal cortical slices from rats caused by CP in vitro. Arch. Toxicol. 1992, 66, 354-358.
9. Srivastava, R.C.; Farookh, A.; Ahmad, N.; Misra, M.; Hasan, S.K.; Husain, M.M. Evidence for the involvement of nitric oxide in cisplatin-induced toxicity in rats. BioMetals 1996, 9 (2), 139-142.
10. Saad, S.Y.; Najjar, T.A.; Daba, M.H.; Al-Rikabi, A.C. Inhibition of nitric oxide synthase aggravates cisplatin-induced nephrotoxicity: effect of 2-amino-4-methylpyridine. Chemotherapy 2002, 48 (6), 309-315.
11. Anderson, M.E.; Naganuma, A.; Meister, A. Protection against cisplatin toxicity by administration of glutathione ester. FASEB J. 1990, 4 (14), 3251-3255.
12. Appenroth, D.; Winnefield, K.; Schroter, H.; et al. Beneficial effect of acetylcysteine on CP nephrotoxicity in rats. J. Appl. Toxicol. 1993, 13, 189-192.
13. Appenroth, D.; Winnefield, K. Role of glutathione for CP nephrotoxicity in young and adult rats. Ren. Fail. 1993, 15, 135-139.
14. Lash, L.H. Glutathione and other antioxidant defense mechanisms. In Comprehensive Toxicology; Renal Toxicology; Goldstein, R.S., Ed.; Elsevier Science Ltd.: Oxford, 1997; Vol. 7, 403-428.
15. Ishikawa, M.; Takayanagi, Y.; Sasaki, K. The deleterious effect of buthionine sulfoximine, a glutathione-depleting agent, on the CP toxicity in mice. Jpn. J. Pharmacol. 1990, 52 (4), 652-655.
16. Ishikawa, M.; Takayanagi, Y.; Sasaki, K. Enhancement of CP toxicity by buthionine sulfoximine, a glutathione-depleting agent, in mice. Res. Commun. Chem. Pathol. Pharmacol. 1990, 67(1), 131-141.
17. Mayer, R.D.; Lee, K.E.; Cockett, A.T. Inhibition of CP-induced nephrotoxicity in rats by buthionine sulfoximine, a glutathione synthesis inhibitor. Cancer Chemother. Pharmacol. 1987, 20 (3), 207-210.
18. Mayer, R.D.; Lee, K.E.; Cockett, A.T. Improved use of buthionine sulfoximine to prevent CP nephrotoxicity in rats. J. Cancer Res. Clin. Oncol. 1989, 115 (5), 418-422.
19. Suzuki, C.A.; Cherian, M.G. The interactions of cis- diamminedichloroplatinum with metallothionein and glutathione in rat liver and kidney. Toxicology 1990, 64 (2), 113-127.
20. Lu, Y.; Kawashima, A.; Horii, I.; Zhong, L. Effects of BSO and L-cysteine on drug-induced cytotoxicity in primary cell cultures: drug-, cell type-, and species-specific difference. Drug Chem. Toxicol. 2004, 27 (3), 269-280.
21. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: application of proliferation and cytotoxicity assays. J. Immunol. Methods 1983, 65, 55-63.
22. Boogaard, P.J.; Zoeteweij, J.P.; Van Berkel, T.J.C.; Van't Noordende, J.M.; Mulder, G.J.; Nagelkerke, J.F. Primary culture of proximal tubular cells from normal rat kidney as an in vitro model to study mechanisms of nephrotoxicity: study mechanisms of nephrotoxicants at low concentrations during prolonged exposure. Biochem. Pharmacol. 1990, 39(8), 1335-1345.
23. Lash, L.H. Use of freshly isolated and primary cultures of proximal tubular and distal tubular cells from rat kidney. In Methods in Renal Toxicology; Zalups, Lash, L.H., Eds.; CRC Press, Inc.: Boca Raton, 1996; 190-215.
24. Zhou, H.; Kato, A.; Yasuda, H.; et al. The induction of cell cycle regulatory and DNA repair proteins in cisplatin-induced acute renal failure. Toxicol. Appl. Pharmacol. 2004, 200 (2), 111-120.
25. Mishra, J.; Mori, K.; Ma, Q.; Kelly, C.; Barasch, J.; Devarajan, P. Neutrophil gelatinase-associated lip-ocalin: a novel early urinary biomarker for cisplatin nephrotoxicity. Am. J. Nephrol. 2004, 24 (3), 307-315.